Araci Ayça, Özşimşek Ahmet, Yuluğ Burak, Karaçay Ertan
Physiotherapy and Rehabilitation Department, Health Science Faculty, Alanya Alaaddin Keykubat University, Alanya, Antalya, Turkey.
Neurology Department, Medicine Faculty, Alanya Aladdin Keykubat University, Alanya, Antalya, Turkey.
J Chiropr Med. 2024 Sep;23(3):114-126. doi: 10.1016/j.jcm.2024.08.010. Epub 2024 Oct 29.
The primary objective of this study was to investigate the impact of myofascial release and craniosacral therapy on the quality of life, pain levels, and range of motion (ROM) in patients with chronic migraine headaches. The secondary aim of this study was to develop a migraine treatment protocol using current craniosacral techniques.
Patients with chronic migraine in the Neurology Department of ALKU Hospital were randomly allocated to 3 therapy groups: (1) Craniosacral Treatment Craniosacral Techniques (CST) + Medical Treatment (MT) (CST group) ( = 24), (2) myofascial treatment (MFT) ( = 24) + MT (MFT group), and (3) MT (control group) only ( = 26). Visual Analog Scale (VAS) for pain, FONSECA for temporomandibular disorder symptom intensity, 24 Hours Quality of Life Questionnaire Scales for quality of life, and Migraine Disability Assessment Score for impairment, Goniometer for Cervical ROM were used for the disability level. Follow-up scores were collected 4 times: at pretreatment (T0), immediately post-treatment (T1), 1 month (T2), and 3 months after treatment ended (T3).
Changes were found in T0 to T1 treatment results, VAS, and ROM angles between the groups. In intragroup evaluations, 24 Hours Quality of Life Questionnaire changes were observed only in the CST group at T0 to T1 to T2 periods ( = .011) while Migraine Disability Assessment Score scores were significantly changed in all groups. Significant changes were also observed in both VAS scores and FONSECA scores of the CST and MFT groups whereas VAS scores decreased significantly, especially in the T0 to T1 to T2 to T3 periods ( < .05). In the evaluation of FONSECA scores both within and between groups, it was observed that the most significant decrease was in the T2 period and there was a difference between the groups ( = .015).
For the participants in this study, CST and MFT techniques reduced migraine headache, temporomandibular disorder level, drug consumption, and functional disability levels, and increased cervical region ROM. These results suggest that CST techniques could be considered in migraine treatment as one of the clinical practical applications within the framework of a certain protocol.
本研究的主要目的是调查肌筋膜放松和颅骶疗法对慢性偏头痛患者生活质量、疼痛水平及活动范围（ROM）的影响。本研究的次要目的是利用当前的颅骶技术制定偏头痛治疗方案。
ALKU医院神经科的慢性偏头痛患者被随机分为3个治疗组：（1）颅骶治疗颅骶技术（CST）+药物治疗（MT）（CST组）（n = 24），（2）肌筋膜治疗（MFT）（n = 24）+MT（MFT组），以及（3）仅MT（对照组）（n = 26）。使用疼痛视觉模拟量表（VAS）、颞下颌关节紊乱症状强度的FONSECA量表、生活质量24小时问卷调查量表、偏头痛残疾评估评分量表评估残疾程度，使用量角器测量颈椎活动范围。随访评分共收集4次：治疗前（T0）、治疗后即刻（T1）、治疗结束后1个月（T2）和治疗结束后3个月（T3）。
发现各组在T0至T1的治疗结果、VAS及ROM角度方面存在变化。在组内评估中，仅CST组在T0至T1至T2期间观察到24小时生活质量问卷调查有变化（P = .011），而所有组的偏头痛残疾评估评分均有显著变化。CST组和MFT组的VAS评分和FONSECA评分也有显著变化，VAS评分显著下降，尤其是在T0至T1至T2至T3期间（P < .05）。在组内和组间FONSECA评分评估中，观察到在T2期下降最为显著，且组间存在差异（P = .015）。
对于本研究的参与者，CST和MFT技术可减轻偏头痛、颞下颌关节紊乱程度、药物消耗量及功能残疾水平，并增加颈椎活动范围。这些结果表明，在特定方案框架内，CST技术可作为偏头痛治疗的临床实际应用之一加以考虑。
